Through important chemistry and the right engineering, there’s new opportunity for CAR T therapeutics to target different forms of cancer with limited toxicity.
- COGs And Biology, Two Endpoints Needlessly At Odds In Advanced Therapy
- The Long Road To U.S. Vaccine Manufacturing
- Compliance, Costs, And Site Readiness In CAR-T Clinical Trials
- All The Ways Global Biopharma Still Grapples With Annex 1
- Managing Operational Challenges In CAR-T Clinical Trial Logistics
- FDA's 483 Playbook: What It Means For Pharma Outsourcing — And What It Doesn't Address
- Organic Impurities: New Draft ICH Q3E Guidance For Leachables And Extractables
- Building Harmonized Real‑World Data In Oncology
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "Successful Cell-Based ADA Collaboration In mRNA Gene Replacement Therapy")
Successful Cell-Based ADA Collaboration In mRNA Gene Replacement TherapyA biotech firm developed a rapid, sensitive, cell-based ADA assay through collaborative innovation, reducing variability and turnaround time while improving performance for mRNA gene therapy.
-
![mAbs GettyImages-1441786721]( "Improve mAb Purification Process Efficiency With Mixed-Mode Resins")
Improve mAb Purification Process Efficiency With Mixed-Mode ResinsDoes your monoclonal antibody (mAb) purification process have three steps? Are you trying to improve purity, yield, and process economics?
-
![GettyImages-1087219366-filling-vials-mechanical]( "Why Choose Robotic Processing For Small Batch Aseptic Filling")
Why Choose Robotic Processing For Small Batch Aseptic FillingReducing human intervention in aseptic filling is critical for safety and cost efficiency. Learn why automation is essential for small-batch applications and how it’s transforming sterile drug manufacturing.
-
![GettyImages-1832921718-pills-medicine-blue-background]( "Automated Testing For Compound Toxicity Effects")
Automated Testing For Compound Toxicity EffectsExplore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.
-
![GettyImages-545581230-lab-research-computer-tablet-teamwork]( "Demonstration Of Scalability For A Novel Fixed Bed Reactor Platform")
Demonstration Of Scalability For A Novel Fixed Bed Reactor PlatformDesigned to enable efficient scalability, a new FBR platform allows operators to use one technology, with a standardized workflow, for their process development, scale-up, and manufacturing processes.
-
![Cytiva]( "Customer Story: Emergent BioSolutions Enhances Aseptic Filling Process")
Customer Story: Emergent BioSolutions Enhances Aseptic Filling ProcessUpgrading outdated filling systems is essential for meeting future production demands and regulatory standards. Learn how one manufacturer modernized its approach to ensure compliance and efficiency.
-
![KNAUER - IJM Tech]( "Scaling Of Impingement Jets Mixing For LNP Drug Production")
Scaling Of Impingement Jets Mixing For LNP Drug ProductionDelve into the intricacies of Impingement Jets Mixing (IJM) technology and its pivotal role in the scalable and reproducible production of Lipid Nanoparticles (LNPs) for drug delivery.
-
![CARR Bio - UFmini]( "Enabling MSC Harvest, Wash, And Concentration")
Enabling MSC Harvest, Wash, And ConcentrationA study demonstrates how a low-shear, closed-system centrifuge achieved over 90% MSC recovery and minimized viability loss, supporting scalable cell therapy manufacturing.
-
![GettyImages-1457289257 patient]( "Quantitative ROI With DCTs")
Quantitative ROI With DCTsThrough dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "A Comprehensive Solution For Adventitious Agent Testing")
A Comprehensive Solution For Adventitious Agent TestingModern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.
NEWSLETTER ARCHIVE
- 03.20.26 -- Lessons From Bringing A New T Cell Class For Autoimmune Diseases To Clinic
- 03.19.26 -- Your Guide To AAV Success: Characterization, QC, And Viral Clearance Strategies
- 03.19.26 -- Powering AI And Synthetic Biology In Therapy Design
- 03.18.26 -- Advance Your MSC Process: New Research, Expert Talks, And Scaling Solutions
- 03.18.26 -- Proteomics Tools: A Resurrection
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
